Damora Therapeutics (DMRA) Other Non Operating Income (2019 - 2025)
Damora Therapeutics (DMRA) posted Other Non Operating Income of $3000.0 for Q4 2025, up 115.79% on a QoQ basis from -$19000.0 in Q3 2025, and down 97.6% year-over-year from $125000.0 in Q4 2024.
Damora Therapeutics (DMRA) Other Non Operating Income (2019 - 2025) Analysis & Trends
Damora Therapeutics' Other Non Operating Income history runs 7 years deep, the most recent figure standing at $3000.0 for Q4 2025.
- Quarterly Other Non Operating Income fell 97.6% year-over-year to $3000.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$78000.0 (down 1660.0% YoY) and the FY2025 annual result came in at -$84000.0, down 566.67% from the prior year.
- Other Non Operating Income was $3000.0 for Q4 2025 at Damora Therapeutics, up from -$19000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $208000.0 in Q3 2021 and bottomed at -$828000.0 in Q4 2022.
- A 5-year average of -$50650.0 and a median of -$12500.0 in 2025 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2022 — Other Non Operating Income plunged 2955.17% — and 2024, when it soared 351.85%.
- Damora Therapeutics' Other Non Operating Income stood at $29000.0 in 2021, then plunged by 2955.17% to -$828000.0 in 2022, then surged by 74.88% to -$208000.0 in 2023, then jumped by 160.1% to $125000.0 in 2024, then sank by 97.6% to $3000.0 in 2025.
- Business Quant data shows DMRA's Other Non Operating Income at $3000.0 in Q4 2025, -$19000.0 in Q3 2025, and -$62000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Damora Therapeutics | 1.00 Bn | 798.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3,000.00 |
| Sep 30, 2025 | -19,000.00 |
| Jun 30, 2025 | -62,000.00 |
| Mar 31, 2025 | -6,000.00 |
| Dec 31, 2024 | 125,000.00 |
| Sep 30, 2024 | -182,000.00 |
| Jun 30, 2024 | 68,000.00 |
| Mar 31, 2024 | 7,000.00 |
| Dec 31, 2023 | -208,000.00 |
| Sep 30, 2023 | -26,000.00 |
| Jun 30, 2023 | -27,000.00 |
| Mar 31, 2023 | 64,000.00 |
| Dec 31, 2022 | -828,000.00 |
| Sep 30, 2022 | -329,000.00 |
| Jun 30, 2022 | 148,000.00 |
| Mar 31, 2022 | -60,000.00 |
| Dec 31, 2021 | 29,000.00 |
| Sep 30, 2021 | 208,000.00 |
| Jun 30, 2021 | -86,000.00 |
| Mar 31, 2021 | 168,000.00 |